← All candidates
Two insider buys in the last year — $911.8K in all.
8 filings on record.
ATYRaTYR PHARMA INC
—
$0.5930
+0.51% · Jul 2
Two insider buys in the last year — $911.8K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys● 3 sells◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ATYR ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Schimmel Paul
Bought $612.4K on Oct 8 — 682,001 sh @ $0.8980, held indirect, 62% of their stake.
First Form 4 on file
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
3 more transactions on Pro →Context
Wall St
$2.86 avg target
+381.8% vs today · 7 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
8 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice